No concomitant occurrence of the n-ras and p53 gene mutations in myelodysplastic syndromes


Play all audios:

Loading...

ABSTRACT Mutations of the N-ras oncogene and p53 tumor suppressor gene were simultaneously investigated in bone marrow cells from 44 patients with myelodysplastic syndrome (MDS) or


MDS-derived leukemia by single-strand conformation polymorphism (SSCP) analysis followed by direct sequencing. The mutations of the N-ras gene were detected only in two cases with


MDS-derived leukemia. Three patients with MDS-derived leukemia and one with refractory anemia with excess of blasts exhibited five mutations of the p53 gene. No concomitant mutations of both


genes were observed in our study, suggesting that alterations of both genes could play an important role in the progression of MDS in a non-cooperative manner. Access through your


institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print


issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to


local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT


BEING VIEWED BY OTHERS GENOMIC VARIATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND KARYOTYPES WITHOUT NUMERICAL OR STRUCTURAL CHANGES Article Open access 02 February 2021 IMPACT OF GENE


ALTERATIONS ON CLINICAL OUTCOME IN YOUNG ADULTS WITH MYELODYSPLASTIC SYNDROMES Article Open access 14 February 2023 MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS-UNCLASSIFIABLE WITH ISOLATED


ISOCHROMOSOME 17Q REPRESENTS A DISTINCT CLINICO-BIOLOGIC SUBSET: A MULTI-INSTITUTIONAL COLLABORATIVE STUDY FROM THE BONE MARROW PATHOLOGY GROUP Article 13 November 2021 AUTHOR INFORMATION


AUTHORS AND AFFILIATIONS * Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan K Mitani, A Hangaishi, S Ogawa, Y Kanda, Y Yazaki & H Hirai * Department


of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan N Imamura * Department of Developmental Biology and Oncology, Research


Institute for Radiation Biology and Medicine, Hiroshima University, Japan K Miyagawa Authors * K Mitani View author publications You can also search for this author inPubMed Google Scholar *


A Hangaishi View author publications You can also search for this author inPubMed Google Scholar * N Imamura View author publications You can also search for this author inPubMed Google


Scholar * K Miyagawa View author publications You can also search for this author inPubMed Google Scholar * S Ogawa View author publications You can also search for this author inPubMed 


Google Scholar * Y Kanda View author publications You can also search for this author inPubMed Google Scholar * Y Yazaki View author publications You can also search for this author inPubMed


 Google Scholar * H Hirai View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS


ARTICLE Mitani, K., Hangaishi, A., Imamura, N. _et al._ No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes. _Leukemia_ 11, 863–865 (1997).


https://doi.org/10.1038/sj.leu.2400666 Download citation * Received: 03 February 1997 * Accepted: 24 February 1997 * Issue Date: 01 June 1997 * DOI: https://doi.org/10.1038/sj.leu.2400666


SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * N-ras * p53 * gene mutation * myelodysplastic syndrome * SSCP